Tradestie Institutional Equity Comparison Engine

ACHV vs PRPO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ACHV Overall Edge

ACHV Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Achieve Life Sciences, Inc. (ACHV) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while PRPO counters with relative strength in Valuation. Fundamentally, ACHV trades at 35.3x Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus PRPO at 15.4x Forward P/E and -5.3% operating margin (+8.3% YoY). In options structure, ACHV sits in BREAKOUT (23rd %ile IV; Dealer Gamma Walls on Pro) against PRPO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner PRPO
ACHV 35.3x vs PRPO 15.4x Fwd P/E
Growth & Margin Winner ACHV
Op Margin 0.0% vs -5.3% ยท YoY +0.0% vs +8.3%
Momentum & Technical Winner ACHV
1Y +43.0% vs +1.8% ยท 52W Pos 69% vs 16%
Options & Structure Winner ACHV
BREAKOUT (23rd %ile IV) vs UNCLASSIFIED (N/A IV)
ACHV NASDAQ
Achieve Life Sciences, Inc.
In Vitro & In Vivo Diagnostic Substances
$6.78
+0.89% 1D
Market Cap $692.8M
1M Return -8.5%
1Y Return +43.04%
Forward P/E 35.3x
Unified AI Score
56.6 / 100 HOLD
Tech 66.0 Fund 58.0 Flow 57.0 Mom 58.9
PRPO NASDAQ
Precipio, Inc. Common Stock
Laboratory Analytical Instruments
$20.35
-8.04% 1D
Market Cap $40.2M
1M Return -4.8%
1Y Return +1.75%
Forward P/E 15.4x
Unified AI Score
32.2 / 100 SELL
Tech 5.0 Fund 31.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ACHV +43.04% PRPO +1.75% Spread: +32.64 pp (ACHV Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ACHV TTM Op. Margin: 0.0% PRPO TTM Op. Margin: -5.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ACHV vs PRPO. Trailing 12-month operating profitability (ACHV 0.0% vs PRPO -5.3%) and valuation multiples (ACHV 35.3x vs PRPO 15.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ACHV (6) vs PRPO (4)
Institutional Metric ACHV PRPO Criterion Row Winner
Market Capitalization Scale $692.8M $40.2M Larger Scale ACHV
Trailing P/E Ratio Valuation 35.3x 15.4x Lower Multiple PRPO
Forward P/E Ratio Valuation 35.3x 15.4x Lower Multiple PRPO
Revenue Growth (YoY) Growth +0.0% +8.3% Higher Growth PRPO
Operating Margin (TTM) Profitability 0.0% -5.3% Higher Margin ACHV
Net Profit Margin Profitability 0.0% -4.1% Higher Margin ACHV
Return on Equity (ROE) Capital Efficiency -845.0% -8.0% Higher ROE PRPO
52-Week Range Position Momentum 69% ($3โ€“$9) 16% ($18โ€“$34) Stronger Trend ACHV
Beta / 30D Volatility Risk Regime 1.73ฮฒ ยท 62% Vol 1.21ฮฒ ยท 96% Vol Lower Realized Risk ACHV
Unified Institutional Score Composite Signal 56.6 / 100 (HOLD) 32.2 / 100 (SELL) Higher Composite ACHV

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ACHV vs PRPO Buy Guide
ACHV BREAKOUT
125d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 23rd %ile
IV Regime Compressed (<25th %ile)
Live ACHV Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PRPO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PRPO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ACHV nor PRPO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.